Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19959339 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia.
Condition: Schizophrenia
Interventions: Drug: Placebo;   Drug: Paliperidone Palmitate

Indicates status has not been verified in more than two years